In this request, the authors outline a study focused on assessing the effect of canagliflozin vs. placebo on liver related outcomes in patients with T2DM and to identify subgroups that are most likely to benefit from treatment. Could the requestors clarify that the trials that are being requested contain the outcomes of interest for this study? In particular, do both trials have information for the primary and/or secondary outcomes outlined in the data request?
Not ApproveIn this request, the authors outline a study focused on assessing the effect of canagliflozin vs. placebo on liver related outcomes in patients with T2DM and to identify subgroups that are most likely to benefit from treatment. Could the requestors clarify that the trials that are being requested contain the outcomes of interest for this study? In particular, do both trials have information for the primary and/or secondary outcomes outlined in the data request?